WOOF
Petco Health and Wellness Company, Inc.
NASDAQ · Consumer Cyclical · Specialty Retail · US
$2.69
+6.83%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 6.0B | 6.0B | 6.1B | 6.3B | 6.0B |
| Cost of Revenue | 3.7B | 3.7B | 3.8B | 3.9B | 3.6B |
| Gross Profit | 2.3B | 2.3B | 2.3B | 2.4B | 2.4B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 2.2B | 2.2B | 2.3B | 2.3B | 2.2B |
| General & Admin Expense | 543.3M | — | 2.2B | — | — |
| Selling & Marketing Expense | — | — | 156.1M | — | — |
| Other Expenses | — | — | — | 1.2B | — |
| Total Operating Expenses | 2.2B | 2.2B | 2.3B | 3.5B | 2.2B |
| Cost and Expenses | 5.9B | 5.8B | 6.1B | 7.4B | 5.8B |
| Operating Income (EBIT) | 128.9M | 120.4M | 7.1M | (1.2B) | 225.6M |
| Non-Operating | |||||
| Interest Income | 7.7M | 6.3M | 3.7M | 3.4M | 1.0M |
| Interest Expense | 129.7M | 131.2M | 143.5M | 150.9M | 101.6M |
| Net Interest Income | (122.0M) | (124.9M) | (139.8M) | (147.5M) | (100.6M) |
| Other Non-Op Income/Expense | (128.3M) | (105.1M) | (116.3M) | (127.5M) | (100.3M) |
| Non-Operating Income (excl Interest) | (6.2M) | (26.1M) | (8.5M) | (7.7M) | 11.6M |
| EBT (Pre-Tax Income) | 581.0K | 15.3M | (109.3M) | (1.3B) | 125.3M |
| Income Tax Expense | (11.0K) | 6.3M | (7.5M) | (27.6M) | 35.3M |
| Bottom Line | |||||
| Net Income | 5.8M | 9.1M | (101.8M) | (1.3B) | 90.8M |
| Earnings from Cont. Ops | 592.0K | 9.1M | (101.8M) | (1.3B) | 89.9M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 5.8M | 9.1M | (101.8M) | (1.3B) | 90.8M |
| Per Share | |||||
| Basic EPS | $0.02 | $0.03 | ($0.37) | ($4.78) | $0.34 |
| Diluted EPS | $0.01 | $0.03 | ($0.37) | ($4.78) | $0.34 |
| Revenue Per Share | $21.00 | $21.32 | $22.37 | $23.38 | $22.73 |
| Shares | |||||
| Basic Shares Outstanding | 285.6M | 279.6M | 273.4M | 267.5M | 265.5M |
| Diluted Shares Outstanding | 290.5M | 286.1M | 273.4M | 267.5M | 266.0M |
| Profitability Metrics | |||||
| EBITDA | 331.1M | 343.2M | 215.3M | (971.8M) | 407.8M |
| D&A | 196.0M | 196.7M | 199.7M | 200.8M | 193.8M |
| EBIT | 135.1M | 146.5M | 15.6M | (1.2B) | 213.9M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Aug 1, 2026